If Koos is intended to do the R/S before the answer of the FDA, the new Shareprice will collapse, I can asure you that. That should be very stupid. The more when the Market noticed that the answer of the FDA will take longer, the more the risk is there that the shareprice will fall/collapse. You never know on forehand when you can get the answer! A Timeframe within you can aspect an answer from the FDA is never a certainty. The longer it takes the deeper the shareprice will fall and what's more important for us the upside of the shareprice, when granted will also be a lot lower.
To me it's a very stupid idea. The best timing bringing out the press release of a R/S will be after the FDA has granted BMSN, whereby Koos put all his cards on the table, giveing the Market more insight information about theit (near) future planning!
Koos needs to win more credibility of the Market. For the moment he has lost a lot. You can't going on fooling the Market!
If this time he is thinking of filling his pockets again the Market will lose all faith in the companies strategy
and the shareprice of ENTB and RGBP will also slip away and lots of shareholders will stop putting their money in BMSN
A fact is that the most R/S did more harm then good when the timing is bad!
Transparacy is what we need. Without that............
